Latest news articles

Added 2 months ago Drug news

Phase III study of RVX 208 fails to meet endpoint in post-ACS diabetes.- Resverlogix

The first phase III study of RVX 208 (apabetalone), from Resverlogix, failed to meet its primary endpoint in a population...

Added 3 months ago Drug news

BD announces publication of an independent analysis of drug-coated balloon safety data for Lutonix for femoropopliteal peripheral arterial disease.- BD (Becton Dickinson)

BD (Becton, Dickinson and Company) a leading global medical technology company,announced the publication of a company-initiated, independent analysis of the...

Added 4 months ago Drug news

IN.PACT AV Access study of IN.PACT drug-coated balloon meets primary endpoints in patients with end-stage renal disease

Medtronic announced the first-ever results from the IN.PACT AV Access clinical study comparing the investigational IN.PACT AV drug-coated balloon (DCB)...

Search all news articles for Peripheral and visceral atherosclerosis

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.



See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Fibrinogen Deficiency in Bleeding

Fibrinogen Deficiency in Bleeding

Fibrinogen is important for blood clot formation and breakdown. It is the first coagulant factor to be reduced to critical levels during massive trauma, cardiac surgery and postpartum haemorrhage that involve excessive bleeding. Persistent fibrinogen deficiency can lead to bleeding complications and an increased risk in mortality. This learning zone looks at both congenital and acquired fibrinogen deficiencies including indications and techniques for diagnosis, trigger level for treatment and treatment options.

Load more


2018 ESC/EACTS Guidelines on myocardial revascularization

These Guidelines represent the third time that the ESC and EACTS have brought together cardiologists and cardiac surgeons in a joint Task Force to review the ever-increasing body of evidence, with the mission of drafting balanced...

Added 5 years ago

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)

In this document, the term ‘peripheral arterial diseases’ encompasses all arterial diseases other than coronary arteries and the aorta. This should be clearly distinguished from the term ‘peripheral artery disease’...

Added 2 years ago

Cardiovascular disease: risk assessment and reduction, including lipid modification

This guideline covers the assessment and care of adults who are at risk of or who have cardiovascular disease (CVD), such as heart disease and stroke. It aims to help healthcare professionals identify people who are at risk of...

Added 5 years ago

Search all guidelines for Peripheral and visceral atherosclerosis

Journal articles

The Comorbidity of Chronic Obstructive Pulmonary Disease and Peripheral Artery Disease - A Systematic Review.

The comorbidity of peripheral arterial disease (PAD) and chronic obstructive pulmonary disease (COPD) is obvious from a clinical point of view, especially as smoking is an important risk factor for both.

Added 3 months ago

Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study).

The Copenhagen City Heart Study is a population-based cohort study. Using baseline data from 3 cohort examinations (1976 to 1978, 1981 to 1983, and 1991 to 1994), we analyzed the gender-specific effect of atrial fibrillation (AF)...

Added 5 months ago

Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options.

Areas covered: Herein, the authors review the most commonly used FDA approved medications for the treatment of obesity, describing their mechanism of action, and the efficacy and safety of the medications as seen in...

Added 9 months ago

Search all journal articles for Peripheral and visceral atherosclerosis

Clinical trials

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)

The primary purpose of this study is to evaluate whether treatment with rivaroxaban and aspirin or rivaroxaban alone is better than aspirin alone in prevention of heart attacks, stroke or cardiovascular death...

Added 7 years ago

Search all clinical trials for Peripheral and visceral atherosclerosis


Leg ulcers - red flag symptoms

Accrediting body
MIMS Learning - Monthly Index of Medical Specialities
Credits available
Registration required
Subscription fee
Search all CME for Peripheral and visceral atherosclerosis